Diabetes

Global health regulators testing carcinogen levels of popular diabetes drug

Illustration of a magnifying glass inspecting a pill
Illustration: Eniola Odetunde/Axios

Health regulators around the world — including the FDA — are investigating whether metformin, a popular drug used to treat Type 2 diabetes, contains unsafe amounts of NDMA, a carcinogen, Bloomberg reports.

What they're saying: "The agency is in the beginning stages of testing metformin," an FDA spokesman told Bloomberg in a statement. "However, the agency has not confirmed if NDMA in metformin is above the acceptable daily intake (ADI) limit of 96 nanograms in the U.S."

The urban-rural health divide is costing lives

Illustration of a weathervane with a caduceus at the top point towards darker skies
Illustration: Sarah Grillo/Axios

The health disparities between urban and rural areas aren't getting any better, new studies published in Health Affairs confirm.

The big picture: Rural areas fell short of every benchmark for improvement in seven major causes of death, according to one study — and others suggest that the situation may never get better for the 62 million Americans who live in rural parts of the country.